Literature DB >> 32910064

The paradox of HIV prevention: did biomedical prevention trials show how effective behavioral prevention can be?

Kevin R O'Reilly1, Virginia A Fonner1, Caitlin E Kennedy2, Ping T Yeh2, Michael D Sweat1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32910064      PMCID： PMC7606697          DOI： 10.1097/QAD.0000000000002682

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.632


× No keyword cloud information.
  41 in total

1.  HIV voluntary counseling and testing and behavioral risk reduction in developing countries: a meta-analysis, 1990--2005.

Authors:  Julie A Denison; Kevin R O'Reilly; George P Schmid; Caitlin E Kennedy; Michael D Sweat
Journal:  AIDS Behav       Date:  2007-12-27

2.  Free condom distribution: what we don't know may hurt us.

Authors:  K R O'Reilly; V A Fonner; C E Kennedy; M D Sweat
Journal:  AIDS Behav       Date:  2014-11

Review 3.  Behavioural interventions for HIV positive prevention in developing countries: a systematic review and meta-analysis.

Authors:  Caitlin E Kennedy; Amy M Medley; Michael D Sweat; Kevin R O'Reilly
Journal:  Bull World Health Organ       Date:  2010-05-28       Impact factor: 9.408

4.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

Review 5.  A Systematic Review of the Effects of Behavioral Counseling on Sexual Risk Behaviors and HIV/STI Prevalence in Low- and Middle-Income Countries.

Authors:  Kristyn Zajac; Caitlin E Kennedy; Virginia A Fonner; Kevin S Armstrong; Kevin R O'Reilly; Michael D Sweat
Journal:  AIDS Behav       Date:  2015-07

6.  FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis.

Authors:  Amy L Corneli; Jennifer Deese; Meng Wang; Doug Taylor; Khatija Ahmed; Kawango Agot; Johan Lombaard; Rachel Manongi; Saidi Kapiga; Angela Kashuba; Lut Van Damme
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

7.  Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study.

Authors:  Ariane van der Straten; Elizabeth R Brown; Jeanne M Marrazzo; Michael Z Chirenje; Karen Liu; Kailazarid Gomez; Mark A Marzinke; Jeanna M Piper; Craig W Hendrix
Journal:  J Int AIDS Soc       Date:  2016-02-04       Impact factor: 5.396

8.  Risk behaviors and risk factors for HIV infection among participants in the Bangkok tenofovir study, an HIV pre-exposure prophylaxis trial among people who inject drugs.

Authors:  Michael Martin; Suphak Vanichseni; Pravan Suntharasamai; Udomsak Sangkum; Philip A Mock; Manoj Leethochawalit; Sithisat Chiamwongpaet; Roman J Gvetadze; Somyot Kittimunkong; Marcel E Curlin; Dararat Worrajittanon; Janet M McNicholl; Lynn A Paxton; Kachit Choopanya
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

Review 9.  Effectiveness and safety of oral HIV preexposure prophylaxis for all populations.

Authors:  Virginia A Fonner; Sarah L Dalglish; Caitlin E Kennedy; Rachel Baggaley; Kevin R O'Reilly; Florence M Koechlin; Michelle Rodolph; Ioannis Hodges-Mameletzis; Robert M Grant
Journal:  AIDS       Date:  2016-07-31       Impact factor: 4.177

Review 10.  Systematic assessment of condom use measurement in evaluation of HIV prevention interventions: need for standardization of measures.

Authors:  Virginia A Fonner; Caitlin E Kennedy; Kevin R O'Reilly; Michael D Sweat
Journal:  AIDS Behav       Date:  2014-12
View more
  1 in total

Review 1.  Behavioral and social interventions to promote optimal HIV prevention and care continua outcomes in the United States.

Authors:  Kristi E Gamarel; Wesley M King; Don Operario
Journal:  Curr Opin HIV AIDS       Date:  2022-03-01       Impact factor: 4.061
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.